Table 2.
Parameters | WBC group | KT group | P | |
---|---|---|---|---|
MDA (p) (μmol/l) |
Before | 2.08 ± 0.47 | 2.30 ± 0.52 | 0.227 |
After | 1.63 ± 0.35 | 2.39 ± 0.52 | <0.001 | |
P ∗ | 0.013 | 0.569 | ||
Δ | −0.45 ± 0.61 | 0.09 ± 0.70 | 0.027 | |
| ||||
MDA (e) (nmol/gHb) |
Before | 0.13 ± 0.01 | 0.17 ± 0.03 | <0.001 |
After | 0.13 ± 0.01 | 0.17 ± 0.05 | 0.010 | |
P ∗ | 0.234 | 0.999 | ||
Δ | 0.00 ± 0.01 | 0.00 ± 0.05 | 0.799 | |
| ||||
TOS (s) (μmol/l) |
Before | 20.69 ± 4.99 | 10.12 ± 3.28 | <0.001 |
After | 15.88 ± 3.77 | 11.97 ± 6.71 | 0.053 | |
P ∗ | 0.006 | 0.485 | ||
Δ | −4.81 ± 5.51 | 1.85 ± 7.80 | 0.010 | |
| ||||
OSI (p/s) (arbitrary unit) |
Before | 19.51 ± 7.75 | 6.84 ± 3.03 | <0.001 |
After | 9.65 ± 3.18 | 10.79 ± 9.02 | 0.637 | |
P ∗ | <0.001 | 0.196 | ||
Δ | −9.87 ± 7.50 | 3.96 ± 8.73 | <0.001 |
P: statistical significance of differences between both groups of patients; P∗: statistical significance of differences between values before and after treatment in particular groups of patients. (p): plasma; (s): serum; (e): erythrocyte lysates; Δ: difference prior to posttreatment.